단클론 항체 시장은 2021년 1,110억 1,000만 달러에서 2028년 2,430억 5,000만 달러에 이를 것으로 예상됩니다. 2021년부터 2028년까지 CAGR 11.8%로 성장할 것으로 예상됩니다.
암 및 기타 만성 질환의 유병률 증가와 다양한 분야에서 COVID-19 사례의 엄청난 증가 지역은 시장 성장을 촉진하는 핵심 요소입니다. 세계 암 연구 기금(World Cancer Research Fund)과 미국 암 연구소(American Institute for Cancer)에 따르면 2020년에 남성의 경우 930만 건, 여성의 경우 880만 건을 포함하여 약 1,810만 건의 암 사례가 기록되었습니다. 다양한 유형의 암 치료에 단클론 항체를 사용하는 것은 아직 2상 및 3상 시험에 있습니다.
전략적 통찰력
북미는 2021-2028년 동안 단클론항체 시장에서 계속 우위를 점할 것으로 보입니다. 미국은 이 지역에서 가장 큰 시장 점유율을 차지하고 있으며 예측 기간 동안 시장에서 계속 지배적인 주주가 될 것으로 예상됩니다. Globocan 2020에서 발표한 통계에 따르면 미국에서 약 1,806,590건의 새로운 암 사례가 진단되었고 약 606,520명이 이 질병으로 사망했습니다. 미국 상무부의 보고서에 따르면 NIST(National Institute of Standards and Technology)는 국립 바이오 의약품 제조 혁신 연구소(National Institute for Innovation in Manufacturing Biopharmaceuticals)에 미화 1억 5300만 달러의 자금을 지원한다고 발표했습니다. 또한 FDA는 COVID-19 유행 기간 동안 단클론 항체 개발에 대한 지원을 확대하고 있습니다.
단클론 항체 시장의 수익성 있는 지역
< h3>시장 통찰력
암 및 기타 만성 질환 유병률의 현저한 증가가 시장 성장 촉진
미국 암 학회 보고서에 따름 , 2019년 1월 현재 암 병력이 있는 약 1,690만 명의 개인이 미국에 거주하고 있습니다. 2030년 1월까지 암 생존자의 인구는 인구 증가와 고령화로 인해 2,210만 명으로 증가할 것으로 추정됩니다. 따라서 암 및 기타 만성 질환의 유병률이 증가함에 따라 단클론 항체(mAb)와 같은 생물학적 제제에 대한 수요도 급증했습니다. 많은 치료 요법 및 비용 효율성 치료의 주요 구성 요소인 생물학적 제제는 암 치료에서 중요한 역할을 합니다.
소스 기반 통찰력
< p>출처에 따라 단일클론항체 시장은 마우스, 키메라, 인간 및 인간화로 분류됩니다. 인간 부문은 2021-2028년 동안 가장 큰 시장 점유율을 차지할 것으로 추정됩니다. 이 부문의 시장 성장은 다양한 종류의 전염병 치료를 위한 인간 단클론 항체의 통합으로 인한 증가에 기인합니다. 예를 들어, Regeneron은 COVID-19에 사용하기 위해 FDA 승인 항체 칵테일인 카시리비맙과 임데비맙을 함께 출시했습니다. 이 약물은 FDA로부터 긴급 사용 승인(EUA)을 받았습니다. 성인과 12세 이상, 체중 40kg 이상의 소아 환자의 경증에서 중등도 COVID-19 치료에 사용됩니다. 또한 다양한 만성 질환에 대한 사용 증가와 첨단 유전 공학 기술의 채택은 시장 부문의 성장을 이끄는 중요한 요인 중 하나입니다.
단클론 항체 시장, 출처별 - 2020 및 2028
지시 기반 통찰력
지시 기반, 암, 자가면역 질환, 염증성 질환, 감염성 질환, 미생물 질환, 다른 사람. 암 부문은 향후 몇 년 동안 시장을 지배할 것입니다. 단일클론항체의 치료적 적용과 관련된 발전은 유방암, 폐암 및 결장암과 같은 다양한 암 유형의 치료에서 성공적인 구현을 가능하게 했습니다. 이러한 항체를 기반으로 하는 약물은 암세포에 신호를 보내고, 세포막 파괴를 유발하고, 면역 체계 억제제를 차단하는 등의 작업을 돕습니다. FDA는 2020년 6월에 전립선암 치료를 위해 올라파립과 루카파립이라는 두 가지 약물을 승인했습니다. 이 약물은 전이되었거나 전이되어 표준 호르몬 치료, 즉 거세 저항성 질병 상태에 대한 반응을 멈춘 전립선암 상태의 남성에게 특히 효과적입니다.
최종 사용자- 기반 통찰력
단클론 항체 시장은 최종 사용자별로 병원, 연구소 등으로 구분됩니다. 병원 부문은 특히 암 치료에서 선호하는 치료 라인으로 채택되는 mAb의 증가로 인해 가장 큰 시장 점유율을 보유하고 있습니다.
< p>단클론 항체 시장에서 활동하는 회사는 전 세계적으로 진화하는 고객 요구를 충족하기 위해 제품 혁신 전략을 채택하고 이를 통해 글로벌 시장에서 브랜드 이름을 유지할 수 있습니다.
단클론 항체 시장 - 세분화
단클론 항체 시장은 출처를 기준으로 인간, 인간화, 키메라 및 쥐로 분류됩니다. 생산 방법에 따라 시장은 체외 및 생체 내로 분류됩니다. 단클론항체 시장은 적응증에 따라 암, 자가면역질환, 감염성 질환, 염증성 질환, 미생물성 질환 등으로 세분화됩니다. 응용 프로그램별로 시장은 치료 응용 프로그램, 진단 응용 프로그램 및 연구 응용 프로그램으로 세분화됩니다. 또한 최종 사용자를 기준으로 시장은 병원, 기타 및 연구 기관으로 세분화됩니다..
단클론 항체 시장 - 지역별
- 북미
- 미국
- 캐나다
- 멕시코
- 유럽
- 프랑스
- 독일
- 이탈리아
- 영국
- 스페인
- 기타 유럽
- 아시아 태평양(APAC)
- 중국
- 인도
< li>대한민국 - 일본
- 호주
- 나머지 APAC
- 남아프리카
- 사우디아라비아
- UAE
- 나머지 MEA
- 브라질
- 아르헨티나
- 나머지 사기
회사 프로필
- Novartis AG
- Pfizer Inc.
- GlaxoSmithKline plc
- Amgen, Inc.
- Daiichi Sankyo Company, 제한됨
- F. Hoffmann-La Roche AG
- AstraZeneca
- Elli Lily and Company
- Bayer AG
< li>Bristol-Myers Squibb Company
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Global monoclonal antibodies market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. In North America, the U.S. is the largest market for monoclonal antibodies market. The US is estimated to hold the largest share in the monoclonal antibodies market during the forecast period. The presence of top players and favorable regulations related to product approvals coupled with commercializing new products are the contributing factors for the regional growth. Additionally, the increasing number of R&D activities is the key factor responsible for the Asia-Pacific regional growth for monoclonal antibodies accounting fastest growth of the region during the coming years.
Novartis AG, Pfizer, Inc., GlaxoSmithKline Plc, Amgen, Inc., Daiichi Sankyo Company, Limited, F.Hoffmann-La Roche AG, AstraZeneca, Elli Lilly and Company, Bayer AG, Bristol-Myers Squibb Company are among the leading companies operating in the global monoclonal antibodies market
The in vitro segment dominated the global monoclonal antibodies market and accounted for the largest revenue of 75,044.50 Mn in 2021.
Food and Drug Administration (FDA) defines monoclonal antibodies as immunoglobulin molecules that are secreted from a population of identical cells. They are homogenous in structure and binding specificity. These are used as multifunctional components for the immune system. They facilitate numerous cellular and humoral reactions to a variety of antigens, which include host and foreign substances.
Significant rise in the cancer and chronic diseases is one of the most significant factors responsible for the overall market growth.
Based on source, human segment took the forefront lead in the worldwide market by accounting largest share in 2020 and is expected to continue to do so till the forecast period.
The List of Companies - Monoclonal Antibody Market
- Novartis AG
- Pfizer Inc.
- GlaxoSmithKline plc
- Amgen, Inc
- Daiichi Sankyo Company, Limited
- F. Hoffmann-La Roche AG
- AstraZeneca
- Elli Lilly and Company
- Bayer AG
- Bristol-Myers Squibb Company
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Jan 2022
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Jan 2022
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jan 2022
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Jan 2022
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Jan 2022
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Jan 2022
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Jan 2022
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)